
Entegris, Inc.
- Jurisdiction
United States - LEI
IYX6OWO7BT5DKO3BYG52 - ISIN
US29362U1043 (ENTG )- Sectors
Scores
- Fair value (Benjamin Graham formula)
-
€72.81 11.8% overvalued - Financial strength (Piotroski F-Value)
-
5
/ 9
- Fundamental strength relative to industry (Mohanram G-Value)
-
1
/ 7
Profile
Entegris, Inc. develops, manufactures, and supplies microcontamination control products, specialty chemicals, and advanced materials handling solutions in North America, Taiwan, China, South Korea, Japan, Europe, and Southeast Asia. Read full profile
Fundamentals
- Net revenue
€2.78B - Gross margin
44.1% - EBIT
€446.22M - EBIT margin
16.0% - Net income
€256.16M - Net margin
9.2%
Statement period: - (published )
Estimates
Fiscal Year | Net revenue | Net income |
---|---|---|
|
| |
|
| |
|
|
Stock price
Dividends
- Last dividend amount
-
$0.10 - Ex date
-
- Payment date
-
- Dividend payout ratio
-
20.2%
Analyst ratings
No analyst ratings available
Insider Transactions
Name | Title | Transaction Date | Shares | Price | Value |
---|---|---|---|---|---|
Rice Susan G. | SVP, Global Human Resources |
|
|
|
|
Haris Clinton M. | SVP & President, APS Division |
|
|
|
|
Congress transactions
Name | Transaction date | Value |
---|---|---|
Lisa McClain | September 12, 2025 | $1.00K–$15.00K |
Earnings Calls
Investor transactions
Name | Shares | Value | Last change | Change type |
---|---|---|---|---|
James Anderson |
|
|
|
Sell |
Peter Brown |
|
|
|
Buy |
Earnings Calls
Latest earnings call: May 1, 2024 (Q1 2024)